Cataracts in congenital toxoplasmosis
- PMID: 18086432
- PMCID: PMC2194289
- DOI: 10.1016/j.jaapos.2007.03.017
Cataracts in congenital toxoplasmosis
Erratum in
- J AAPOS. 2008 Feb;12(1):109. Latkany, Paul [added]; Troia, Robert N [added];Jalbrzikowski, Jessica [added]; Kasza, Kristen [added]; Karrison, Ted [added]; Cezar, Simone [added]; Sautter, Mari [added]; Greenwald, Mark J [added]; Mieler, William [added]; Mets, Marilyn B [added]; Alam, A
Abstract
Purpose: To determine the incidence and natural history of cataracts in children with congenital toxoplasmosis.
Methods: Children referred to the National Collaborative Chicago-based Congenital Toxoplasmosis Study (NCCCTS) between 1981 and 2005 were examined by ophthalmologists at predetermined times according to a specific protocol. The clinical course and treatment of patients who developed cataracts were reviewed.
Results: In the first year of life, 134 of 173 children examined were treated with pyrimethamine, sulfadiazine, and leukovorin, while the remaining 39 were not treated. Cataracts occurred in 27 eyes of 20 patients (11.6%, 95% confidence interval [7.2%, 17.3%]). Fourteen cataracts were present at birth and 13 developed postnatally. Locations of the cataracts included anterior polar (three eyes), anterior subcapsular (six eyes), nuclear (five eyes), posterior subcapsular (seven eyes), and unknown (six eyes). Thirteen cataracts were partial, nine total, and five with unknown complexity. Twelve cataracts remained stable, 12 progressed, and progression was not known for 3. Five of 27 eyes had cataract surgery, with 2 of these developing glaucoma. Sixteen eyes of 11 patients had retinal detachment and cataract. All eyes with cataracts had additional ocular lesions.
Conclusions: In the NCCCTS cohort, 11.6% of patients were diagnosed with cataracts. There was considerable variability in the presentation, morphology, and progression of the cataracts. Associated intraocular pathology was an important cause of morbidity.
Figures


References
-
- Taylor D. Congenital cataracts: changing perspective. In: Cotlier E, editor. Congenital Cataracts. Austin, TX: Landes Company; 1994. pp. 3–9.
-
- James LM, McClearon AB, Waters GD. Congenital malformation surveillance data for birth defects prevention: Metropolitan Atlanta Congenital Defects Program (MADCP) 1968–1991 and birth defects monitoring program (BDMP) 1970–1991. Tetralogy. 1993;48:545.
-
- McLeod R, Boyer K, Karrison T, et al. Outcome of treatment for congenital toxoplasmosis, 1981–2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006;42:1383–94. - PubMed
-
- McAuley J, Boyer K, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis. The Chicago Collaborative Treatment Trial. Clin Infect Dis. 1994;18:38–72. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical